
Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

US provider of royalty-based growth capital for software and tech-enabled services companies

Cypress Growth Capital offers an alternative to equity funding. Instead of selling shares, a company repays through a fixed share of its future revenue until an agreed limit is reached, at which point the obligation ends.
SaaS and tech-enabled services companies throughout the United States. Its news mentions funding for a Dallas digital product engineering firm that IBM later acquired.
Summary written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
Cypress Growth Capital is ranked on 1 TrustList ranking at #23.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Cypress Growth Capital has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
Of the top 61 here, 21 also cover artificial intelligence and 19 also cover seed stage; 11 also work in London and 9 also work in San Francisco.
Behind Curiosity VC, ahead of Episode 1 (company).
As of 2026-11-01. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Cypress Growth Capital.
Similar listings buyers compare against this one.

Startup accelerator running programmes for early-stage and scaling technology founders in the North East of England

Product discovery software for B2B and B2C sellers, covering search, guided selling and product content

Startup accelerator and early-stage investor running intensive batches for new technology founders

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Seed-stage venture firm of former founders backing health-focused and B2B SaaS companies
Everything here links back to the same verified catalogue. Pick your next stop.